eLabNext, a subsidiary of the Eppendorf Group, specializing in a Digital Lab Platform featuring lab inventory management systems (LIMS), electronic lab notebooks (ELN), and artificial intelligence (AI)/machine learning (ML) solutions for life science laboratories, has joined forces with Promega Corporation, a renowned global leader in innovative technologies for the life science industry. The collaboration aims to facilitate easy access to Promega’s standard operating procedures (SOPs) via eLabNext’s eLabMarketplace.
This strategic partnership will make select protocols related to Promega’s Wizard™ Extraction Chemistries, GoTaq® Master Mixes, and Bioluminescence Glo® Assays products available on eLabNext’s web-based protocol and SOP management platform, eLabProtocols. These protocols can seamlessly integrate into users’ eLabJournal, which is eLabNext’s user-friendly and fully customizable ELN platform.
Zareh Zurabyan, Head of eLabNext, Americas, Eppendorf Group Company, highlighted the increasing demand for easily accessible protocols in response to the growing trend of lab digitization and the rising significance of AI in biotechnology. By incorporating Promega’s SOPs directly into their platform, eLabNext aims to streamline scientists’ workflows and provide real-time updates on the latest protocols.
Tom Livelli, Vice President of Life Science Products and Services at Promega, emphasized their commitment to offering digital tools that enhance accessibility to their cutting-edge technologies across various research sectors. The collaboration with eLabNext enables the adaptation of reagent protocols on the eLabProtocols platform, fostering improved collaboration and knowledge sharing among researchers.
The integration of Promega’s protocols exemplifies the customizable nature of eLabNext’s platform through eLabMarketplace, showcasing its open approach to meeting the diverse needs of laboratory settings.